Could this new treatment free kidney transplant patients from lifelong pills?
Disease control
Recruiting now
This early-phase study tests a treatment called Sip-Tego in 12 adults with kidney failure who are getting a living-donor kidney transplant. The goal is to help the body accept the new kidney so patients can take fewer or even no anti-rejection drugs over time. The study checks sa…
Phase: EARLY_PHASE1 • Sponsor: Tatsuo Kawai, MD, PhD • Aim: Disease control
Last updated May 15, 2026 11:53 UTC